Look, I’ve spent the last couple of years bouncing between marketing strategy and backend dev, which eventually dragged me straight into AI ethics and consciousness studies. From where I sit, panpsychism makes a lot more sense than trying to shoehorn subjective experience into a purely computational framework. If consciousness is fundamental rather than emergent, then psychedelics aren’t just “tripping the brain”—they’re temporarily decoupling the predictive machinery we use to filter reality. That aligns pretty well with predictive processing models in cognitive science, where depression often looks like an overactive threat-detection loop. DMT might just be hitting the reset button on that stuck circuitry.

I’m not saying it’s magic. It’s pharmacology, period. But the psychological shift? That’s where it gets interesting. Carl Jung famously argued that the psyche has its own architecture, and that psychedelics might be forcing a confrontation with repressed material rather than just chemically masking it. If that’s true, then the real question isn’t whether DMT works, but whether a single dose can actually rewire entrenched neural pathways, or if it’s just a powerful temporary anesthetic for a much deeper problem. The trial’s sample size is tiny, the follow-up is short, and we’re still blind to long-term tolerance or rebound effects. I’m cautiously optimistic, but I’m not buying the miracle narrative until we see rigorous, blinded replications with meaningful longitudinal data. Until then, I’ll keep watching the science, not the headlines.